VANECK BIOTECH ETF - USD |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 153.5 EUR | +0.18% |
|
+1.07% | +1.82% |
Investment objective
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 311.4 USD | +0.96% | +3.70% | +8.12% | 19.50% | ||
| 428.6 USD | -0.31% | +4.47% | +5.33% | 11.25% | ||
| 67.65 USD | +0.16% | +3.35% | -16.49% | 9.94% | ||
| 984.6 USD | +0.79% | +1.51% | +12.11% | 8.97% | ||
| 128.3 USD | +2.11% | +5.99% | +29.03% | 5.32% | ||
| 231.1 USD | +0.92% | +0.87% | -0.10% | 4.71% | ||
| 226.9 USD | +0.68% | +3.64% | -12.32% | 4.58% | ||
| 315.6 USD | +1.96% | +0.33% | +11.48% | 4.00% | ||
| 115.6 USD | +2.49% | +2.45% | -16.99% | 3.79% | ||
More news
In partnership with
| Date | Price | Change |
|---|---|---|
| 14/05/24 | 153.5 | +0.18% |
| 13/05/24 | 153.2 | +0.47% |
| 10/05/24 | 152.5 | +0.13% |
| 09/05/24 | 152.3 | -0.01% |
| 08/05/24 | 152.3 | +0.03% |
Other stock markets
Real-time BOERSE MUENCHEN
Last update May 14, 2024 at 08:47 pm
More quotesETF Ratings
 |
Description
| US92189F7261 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Biotech 25 Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
18/12/2011
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 29/04/2024 )
| AuM (EUR) | 387 M€ |
|---|---|
| AuM 1M | 417 M€ |
| AuM 3 months | 432 M€ |
| AuM 6 months | 396 M€ |
| AuM 12 months | 457 M€ |
- Stock Market
- ETF
- VEFU ETF
